Cheapest Semaglutide Pill Without Insurance: What It Really Costs in 2026

By the WPG Research Team · Last verified: August 22, 2026 · Our pricing methodology · Advertising disclosure

The cheapest semaglutide pill without insurance is the FDA-approved Wegovy pill at $149 for a 30-day bottle of the 1.5 mg starting dose. The 4 mg bottle is also $149 only when an eligible prescription is filled by August 31, 2026. Its standard price is $199. The 9 mg and 25 mg bottles are $299.

Three things change your real total: your dose, who writes your prescription, and what you are treating.

Now the part nobody puts in the ad. The medicine can cost $149 at the start while the complete route costs more. A doctor visit or care plan is a separate charge. And the 4 mg deadline follows the fill date, not the day you first take the 1.5 mg pill. We will show you the dose calendar, the 90-day total, the first-year total, every care fee, and the prepaid commitment that lowers the cost of the maintenance pills you use in year one by $500—but asks for $2,988 up front.

⏱ Time-sensitive: Novo's published $149 offer for the 4 mg Wegovy tablet ends August 31, 2026. The prescription must be filled by that date. Beginning September 1, the standard 4 mg price is $199. The 1.5 mg price stays $149 under the current offer terms.

Quick answer, by your situation

Not the right page for you if you are shopping only for a compounded lozenge, drop, gum, or sublingual product. Those are a different category with different rules, and we cover them separately in our compounded oral GLP-1 guide. Stick with us if you want the FDA-approved semaglutide tablet at the lowest honest cash price—or if you need to see whether a compounded headline really beats it.

What is the cheapest semaglutide pill without insurance?

The cheapest FDA-approved semaglutide pill without insurance is the Wegovy tablet at $149 for a 30-day bottle of 1.5 mg. The 4 mg bottle is also $149 only through the August 31, 2026 fill deadline; after that it is $199. In the current compounded offers we verified, most other oral or under-the-tongue semaglutide formats start at $199 to $299. Strut advertises one from-$99 exception, but its own page says medical necessity is required and final pricing is determined after consultation.

Here is the thing that trips people up. “Semaglutide pill” is not one product. Right now it can mean an FDA-approved weight-management tablet, an FDA-approved diabetes tablet, the Rybelsus product being retired, or a compounded oral or sublingual product that is not FDA-approved.

We put all four lanes in one table.

The Semaglutide Pill Ledger — every U.S. lane we could verify

Read that table twice, because it flips the thing everybody assumes.

The approved semaglutide pill is the cheap one at the starting dose. For years, the whole reason people bought compounded semaglutide was price—brand-name GLP-1s could run near or above $1,000 a month while compounded versions ran around $200. The Wegovy pill changed that cash comparison. Its starting price now undercuts most current compounded oral offers we could verify.

So if you came here hunting for a cheap knockoff pill because the real one seemed out of reach—the real one may be the cheap one now. You can stop hunting long enough to compare the whole route.

The three different things people mean by “cheapest”

This is where most comparison pages fall apart, and it is why the numbers you are seeing do not match each other.

1. The cheapest bottle of medicine. That is $149 for the 1.5 mg Wegovy bottle under Novo's current self-pay terms.
2. The cheapest complete start. That is the medicine plus the person who evaluates you and writes the prescription. It can be $149 plus your own clinician's visit, $188 through GoodRx or Ro, $198 through Walgreens, or hundreds more when a full year is prepaid.
3. The cheapest route that also takes care of you. That includes the prescription, dose changes, side-effect questions, refills, and messages. At the 25 mg maintenance dose, the current medicine-plus-care total is about $338 per GoodRx monthly cycle, $398 per Sesame 28-day cycle, or $448 per Ro monthly cycle.

Those are three different questions with three different answers. Every page we checked answers one of them and acts like it answered all three.

We are going to answer all three, in that order.

💰 See the whole number before you choose a provider

The table below separates the medicine from the care fee and shows cash due at the start, through 90 days, and through one year. No email. No signup. No fake “starting at” number.

→ Jump to the True Cash Cost Index

Is the $149 price real, or does it disappear at checkout?

The $149 price is real and comes from Novo Nordisk's published self-pay terms. It covers one 30-day bottle of the 1.5 mg Wegovy tablets. It also covers one 30-day bottle of 4 mg only when an eligible prescription is filled by August 31, 2026. It does not cover a clinician visit, a care membership, lab work, or the 9 mg and 25 mg bottles later. Eligibility, participating-pharmacy processing, stock, and current program terms still apply.

We verified the dose prices and deadline on NovoCare's official pricing terms on August 22, 2026. It is not a made-up affiliate price. But the way some pages shorten the offer leaves out a lot.

Here is something almost nobody has put side by side

Right now, two 4 mg semaglutide tablets from the same manufacturer carry different cash prices under different brand offers.

Fifty dollars apart through the deadline. On September 1, both published prices are $199 under the current terms.

That does not make the brands interchangeable. They have different labels, NDCs, and approved uses. The useful finding is narrower: Novo is running a temporary 4 mg offer on Wegovy while its published Ozempic 4 mg price stays $199. The right brand is still a clinical and prescribing decision, not a checkout trick.

The same offer, summarized two different ways

While checking the deadline, we found something worth knowing before you walk up to a counter. Novo and Walgreens summarize the offer differently:

Those summaries can lead to different expectations. The safest rule is simple: go by the dose-specific Novo terms and get the 4 mg checkout price confirmed before it is filled. Starting treatment before August 31 does not by itself guarantee that the later 4 mg fill qualifies.

Headline vs. what it actually means

This is the table we wish somebody had handed us:

Nothing on that list is automatically a scam. The terms are published. It is just that the medicine price, care price, billing clock, and dose price live on different pages.

That is what this page is for.

What happened to the $49 semaglutide pill everyone was talking about?

Hims & Hers announced access to a compounded semaglutide pill on February 5, 2026, with a $49 first month on a five-month prepaid plan. FDA publicly objected to marketing non-FDA-approved compounded GLP-1 drugs as the same as approved drugs the next day. Hims stopped offering the pill on February 7. Novo sued on February 9, then voluntarily dismissed the case without prejudice on March 9 after the companies reached an agreement. The $49 compounded pill is not a current Hims offer.

If you are here because you saw a headline about a cheap semaglutide pill and cannot find it anywhere—you are not losing your mind, and you are not late to some secret. Hims offered access to it for about two days.

Here is the whole thing, in order:

Eight months. Several separate changes to what a “semaglutide pill” even means.

That is why old search results feel broken. Some were written when Rybelsus was the only FDA-approved semaglutide tablet. Others still repeat the $49 Hims headline after the product disappeared.

You were not wrong. The market moved.

Does the $149 price go up later?

Yes, and the label schedule lets you map the medicine cost. The Wegovy tablet starts at 1.5 mg for days 1–30, moves to 4 mg for days 31–60, then 9 mg for days 61–90, and reaches the 25 mg maintenance dose on day 91. Under current cash terms, the medicine is $149 in month one, either $149 or $199 in month two depending on the 4 mg fill deadline, and $299 from the 9 mg dose onward.

This is the single most useful thing on this page, so we are going to show all of it.

Here is the part almost nobody prints: the Wegovy tablet label counts dose changes in days, not weeks. The injection follows a weekly schedule. That is a different calendar.

Your price calendar

Note what happens when you reach 9 mg. The bottle price jumps to $299. That is a $150 increase from the temporary $149 4 mg price, or a $100 increase from the standard $199 4 mg price.

The 90-day medicine number

The deadline follows the fill, not merely your treatment start date. Do not assume you get the $597 route until the pharmacy confirms the 4 mg price.

The first-year medicine number

That last row needs one giant clarification.

A selected-provider 12-fill medication commitment prices 9 mg and 25 mg bottles at $249 instead of $299. That saves $50 on each maintenance bottle. You use ten maintenance bottles during the first 12 treatment months, so the medicine consumed in that year is $500 cheaper.

But the verified WeightWatchers version is paid up front: $2,988 for 12 maintenance fills. It is not a gentle $249 charge each month.

Medicine used vs. cash due

The commitment saves $600 across its full 12 maintenance fills compared with twelve $299 fills. Only ten of those maintenance fills are used inside your first treatment year, which is why the first-year treatment-use savings is $500.

The catch is honest and simple: a 12-fill commitment means a large prepayment. In the WeightWatchers terms we verified, refunds apply only to unshipped fills and are recalculated against the $299 standard price. The care membership is separate. Read the exact provider's terms before you pay, because the commitment and refund rules can differ by partner.

One more thing, so you are not blindsided: these are label-schedule estimates. If you do not tolerate a dose, the label says your prescriber can delay escalation. That changes both the timing and the total. That is a medical decision, not a budgeting trick.

✅ You now know the medicine number. Choose the next door that fits.

Already have a clinician? Use the verified NovoCare prescriber details and keep the care fee out of your bill.

Need an online clinician and ongoing dose support? See Ro's current Wegovy pill route. It starts at $39 for care plus $149 for medicine, or $188 total in month one. At maintenance on the monthly care plan, the honest total is $448, not $298.

Medicine is always billed separately from Ro's care fee.

Can I just stay on a lower dose to keep paying $149?

No—not as a money decision. The current label sets 25 mg once daily as the maintenance dose for Wegovy tablets. The 1.5 mg, 4 mg, and 9 mg strengths are steps on the way up, not discount tiers you choose. Dose is a clinical decision your prescriber makes, not a budget lever you pull.

We are answering this because people ask it constantly, and because a lot of pages dodge it.

The lower doses exist to help your body adjust. If you cannot tolerate a dose during escalation, the label says the prescriber may delay the next increase. If you cannot tolerate 25 mg, the label says to consider switching to the 1.7 mg Wegovy injection once weekly.

If money is the reason you are thinking about staying low, say that directly to your prescriber. There may be real options—a maintenance commitment, an eligible coverage path, HSA or FSA funds, or a different medication—that do not involve changing treatment on your own.

That is a conversation, not a checkout decision.

Where do you actually buy it for $149?

The clearest verified $149 path is Novo's own self-pay program: home delivery through NovoCare Pharmacy or pickup at a participating local pharmacy after the offer is processed. Both require a valid prescription. A pharmacy can fill the medicine; it cannot decide that the medicine is right for you or write the prescription.

Some retail pages name specific chains as guaranteed $149 doors. We would not promise that. Stock, participation, and offer processing can change by location. The manufacturer-supported home-delivery and participating-pickup routes are the part we could verify cleanly.

The one thing standing between you and $149

Every medicine-only route starts with the same barrier: you need a licensed prescriber who evaluates you and decides the drug is appropriate.

If you already have a primary care clinician, OB-GYN, endocrinologist, or another clinician who knows your history and can prescribe in your state, that can be your cheapest path in America. It is free advice from a site that makes money when some readers choose a partner instead.

🎁 Take this to your prescriber

You can print or copy this block. It contains the routing details NovoCare publishes for prescribers who cannot find the pharmacy in an electronic system:

NovoCare Pharmacy
2400 Sand Lake Rd, Ste. 200B
Orlando, FL 32809
Phone: 1-833-949-5527
Fax: 1-833-947-0246
NPI: 1710671854
NCPDP: 5758074
NovoCare says a prescriber may be able to add the pharmacy manually with these details.

Four questions are worth asking at the visit:

1. Is the Wegovy tablet appropriate for my approved use and health history?
2. Who handles the 4 mg, 9 mg, and 25 mg prescriptions as my dose changes?
3. Can dose questions and refills be handled by portal message, or does each change require a paid visit?
4. Once I am stable on one dose, is a 60- or 90-day fill appropriate and available?

Do not ask for a 90-day supply of one starter strength just to save time. The label changes the strength every 30 days during escalation. NovoCare does offer 90-day fills when the prescription itself is appropriate for 90 days.

We do not get paid when you use this card. We would still rather you did when it is your cheapest clean path.

What is the cheapest way to get the prescription?

If you already have a clinician who will prescribe the tablet, that is usually cheapest: pay the clinician's normal visit cost, then $149 for the first bottle. If you need online care, GoodRx Care Direct and Ro both start at $188 including the $149 medicine; Walgreens starts at $198 with no subscription. The biggest differences appear after month one, when care fees keep renewing.

This is our True Cash Cost Index. Same columns. Same medicine schedule. Same time periods. No provider gets to hide the medicine in one row and the membership in another.

All fixed totals below assume the 4 mg bottle qualifies for the temporary $149 offer and the patient follows the label schedule without a delayed dose increase. Add $50 to each 90-day and first-year total if the 4 mg fill uses the standard $199 price. Taxes, optional services, lab charges not listed in the plan price, and your own clinician's unknown fees are not included.

What changed when we used the real billing clocks

The Sesame row is higher than a simple “$99 × 12” estimate because its monthly plan renews every 28 days, not once per calendar month. That puts four $99 charges inside 90 days and 13 charges inside the first 364 days.

Walgreens stays a formula because its own page says each needed follow-up costs $49. Nobody can know your visit count before your clinician knows how treatment is going.

The spread from the medicine-only route at $3,288 before clinician fees to Ro's monthly route at $4,966 is $1,678. The medicine schedule is the same in both rows. The difference is care.

We left the “pays us?” column in on purpose. Several of the cheapest routes earn us nothing. We would rather you trust the table.

The honest part

Ro is not the cheapest way to buy this pill. If your regular clinician will write and manage the prescription, the medicine starts at $149. Ro starts at $188 because it adds a $39 first-month care fee.

And once the introductory month ends, the maintenance total is not $298. It is $149 for monthly care + $299 for the 25 mg medicine = $448 per month. On the annual care plan, the same maintenance math is about $74 + $299 = $373 per month equivalent, but the $888 care charge is paid up front.

If the lowest possible number is your only priority, use the prescriber details above with your own clinician. That is the answer. Go do it.

But here is why the gap exists. Ro sells the part many people are stuck on: the evaluation, prescription if appropriate, ongoing provider access, messages, refill management, dose support, and check-ins. The medicine is still a separate line item.

Ro's public insurance checker covers select GLP-1 injection pens. We did not find support for telling readers that it checks Wegovy tablet coverage. Treat the Wegovy pill route through Ro as cash pay unless Ro or your plan confirms otherwise.

If you have been putting this off for six months because you do not have a clinician and do not know where to start—the $39 is not the expensive part. The six months is.

Does that sound like your situation?

If you need a prescriber and want one program to handle the follow-up work, Ro is a guided online route to the FDA-approved pill—not the cheapest medicine-only route.

→ See current Wegovy pill pricing and begin Ro's clinical intake

First-month care is $39 and the 1.5 mg medicine is $149, for $188 total before any unlisted extras. Monthly care is $149 after the first month. Medicine stays separate.

Already have a clinician? Skip this and use the free prescriber card instead. We mean it.

What does each route actually include?

Every route in this section can lead to the same FDA-approved Wegovy tablet when a clinician decides it is appropriate. What differs is the care wrapped around it. Compare what you are getting for the fee, not just the fee.

Your own clinician + a $149 pharmacy route

Best when the prescription problem is already solved.

You pay your normal visit cost, the clinician sends the prescription to NovoCare Pharmacy or another participating pharmacy, and you pay the dose-specific self-pay price. Nothing else is required by the manufacturer route.

Watch out for: your clinician may not prescribe weight-management medication, may want labs first, or may require another visit for dose changes. Ask before you assume. Also ask whether routine dose questions can be handled through the patient portal. That can be the difference between one visit and several.

Walgreens Weight Management — $49 a visit, no subscription

Best if you need an online prescriber but refuse to sign up for anything recurring.

The initial video visit starts at $49. Follow-up chat visits and additional video visits cost $49 each when needed. There is no care subscription. The medicine is separate, and Walgreens says the prescription can be sent to Walgreens or another pharmacy.

Watch out for: the program is built for self-pay weight-management care. It does not promise a fixed number of visits, so nobody can give you one honest annual total in advance. The formula is simple: medicine plus $49 times the number of paid visits.

GoodRx Care Direct — $39 a month

Best low fixed monthly care fee we could verify.

The plan is $39 per month. Medicine is billed separately. After the evaluation, the prescription can be sent to the pharmacy you choose if the clinician prescribes it.

Watch out for: it auto-renews until you cancel, and GoodRx says it is not available in Alabama or Louisiana. Cancel at least one day before renewal to avoid the next charge. Also, do not confuse GoodRx Care with a free GoodRx pharmacy coupon. They are different products. The coupon does not write a prescription.

Ro — $39 first month, then $149/month

Best when you want one place handling the clinical follow-up and you will pay for that.

Ro's program can provide access to Wegovy tablets, Wegovy injections, Zepbound, Foundayo, and other options when clinically appropriate. The care plan includes provider access, messages, dose support, side-effect support, and check-ins. Medication is billed separately.

Ro also advertises multi-month savings on some Wegovy tablet maintenance fills. Verify the exact payment and refund terms shown at your checkout. The 12-fill commitment terms we could fully verify came from WeightWatchers, not Ro, so we are not copying one partner's refund rules onto another.

Watch out for: two line items. The $39 ad is the first month of care, not the medicine. On the monthly plan, the honest maintenance total is $149 care + $299 medicine = $448. The first-year total is $4,966 under the dose and offer assumptions used above. Annual care brings the first-year total to $4,176, but asks for $888 up front.

Sesame — $99 every 28 days, or about $708 for the annual plan

Best if you want to see available clinicians and program details before committing.

Sesame's month-to-month program costs $99 every 28 days. Medicine is separate. Its annual plan saves $480 against twelve $99 plan periods, putting the annual care charge at about $708 paid at signup.

Watch out for: “monthly” means every 28 days. That creates 13 care charges inside 364 days. Sesame says a full first-month refund is available only when cancellation happens at least three hours before the initial visit. After that visit, the first month is not refundable, prior plan fees are nonrefundable, and cancellation stops future renewal rather than erasing past charges.

Want to compare the clinician-choice route?

→ See Sesame's current weight-loss program terms

Month-to-month avoids an annual prepayment, but it renews every 28 days. Read the charge date and cancellation terms before the first visit.

What billing surprises are in the fine print?

The biggest surprise is not a secret scam. It is usually one of four ordinary things: the medicine is separate, the plan renews faster than a calendar month, each follow-up is another paid visit, or a discount requires a large prepayment.

Three testimonial quotes in the source draft could not be traced to stable review pages, so they are not on this medical-cost page. The providers' own billing terms give you something more useful anyway.

This is why the cost table separates medicine used, care fees, and cash due. A low monthly equivalent can still create the largest charge on day one.

Now you will not be surprised.

What about the $99 “oral semaglutide” I keep seeing advertised?

Compounded oral semaglutide is a different finished product made by a compounding pharmacy, and it is not FDA-approved. In the current offers we could verify, most compounded oral or under-the-tongue formats start at $199 to $299. Strut advertises a from-$99 lozenge, but its own page limits the offer to cases where a clinician finds medical necessity because the patient failed or cannot use a commercially available GLP-1, and final pricing is determined after consultation.

First, a definition, because this word does a lot of work in GLP-1 marketing.

Compounding is when a licensed pharmacy prepares a medication for a patient-specific need under federal and state rules. A 503A pharmacy generally compounds based on a prescription for an identified patient and is mainly overseen by state boards of pharmacy, with FDA authority still applying. A 503B outsourcing facility is registered with FDA, faces more federal oversight, and may prepare larger batches under a different legal pathway.

Neither pathway turns the finished compounded product into an FDA-approved drug. FDA does not review each finished compounded product for safety, effectiveness, quality, or how much medicine reaches the bloodstream before it is sold.

That does not make every compounded prescription improper. Compounding can meet real patient needs. It does mean the legal and evidence lane is different from Wegovy.

The compounded oral market we verified on August 22, 2026

Compare the current rows to $149.

About that $99

We opened Strut Health's own page on August 22, 2026. It says three things a shopper needs before treating the headline as a locked price:

1. The product is limited to patients who fail or cannot use commercially available GLP-1 medication, with medical necessity decided by a licensed clinician.
2. The listed formula includes semaglutide and vitamin B6. It is not the same finished formula as Wegovy tablets.
3. An online consultation is required and final pricing is determined after review.

Adding vitamin B6 does not automatically make a copy legal. The prescription still has to meet every applicable federal and state compounding condition, including a real patient-specific basis when the approved product can meet the need.

We will also tell you the thing the review sites skip: FDA sent Strut Health a warning letter dated February 20, 2026. FDA said the site made false or misleading statements about the identity of the compounder and claims that implied FDA approval, safety, or effectiveness. Strut's current page states that the compounded product is not FDA-approved.

None of that proves every Strut prescription is improper. It means the $99 headline does not mean what a first-time bargain shopper may assume.

Where the law stands right now, plainly

• FDA determined the shortage of semaglutide injection products was resolved on February 21, 2025. That ended the shortage-based enforcement window that had supported widespread copying of the injectable products.
• On April 30, 2026, FDA proposed excluding semaglutide, tirzepatide, and liraglutide from the 503B Bulks List because the agency did not find a clinical need for outsourcing facilities to compound those drugs from bulk substances.
• That proposal is not final. It is narrower than a blanket ban on every patient-specific compounded prescription.
• A 503A pharmacy may still compound for an identified patient when all federal and state conditions are met. State oversight alone does not erase FDA rules.

So: not universally banned, but much narrower than “anyone can sell a cheaper copy.”

FDA also reported 990 adverse-event reports associated with compounded semaglutide as of May 31, 2026. FDA says those reports do not always contain enough information to determine that the compounded drug caused the event. That is a signal to take seriously, not proof that every report had one cause.

One safety note we are not going to soften. There is no FDA-approved generic semaglutide. A product advertised as “generic semaglutide” is not an FDA-approved generic equivalent. FDA's BeSafeRx program can help you check an online pharmacy before sending money.

What evidence exists for compounded oral semaglutide?

The Wegovy trial proves what happened with the FDA-approved 25 mg Wegovy tablet used under its studied schedule. It does not prove that a compounded lozenge, drop, gum, sublingual product, or alternate tablet has the same absorption or result.

As of August 22, 2026, we found no published human trial of the specific compounded oral or sublingual products in the table above. That is not an accusation. It is the edge of the evidence.

Who the compounded lane is actually for

The clean reason is not “I found a coupon.” It is a patient-specific medical need that the approved product cannot meet, documented by a clinician and filled under the rules that apply to the pharmacy.

Examples may include a clinically necessary dosage form or ingredient change, but the prescriber and pharmacy—not the ad—must decide whether the situation qualifies.

If the approved morning routine or dosage form may not work for you, do not start at checkout.

Start with the right question: which FDA-approved or lawfully compounded format can meet your medical needs and your daily routine?

→ Take the free 60-second GLP-1 matching quiz

You will get a next-step path based on pill versus injection, cash versus coverage, existing clinician versus no clinician, and the timing rules you can actually follow.

Wegovy pill vs. Ozempic pill vs. Rybelsus — which one are you looking for?

All three contain semaglutide in a swallowed tablet, but they have different labels, uses, formulations, doses, and cash prices. Wegovy tablets are for approved weight and cardiovascular uses and start at $149. Ozempic tablets are for type 2 diabetes and also start at $149. Rybelsus is being replaced in the U.S.; its published list price is $997.58 per package before insurance or discounts.

Sort yourself in one line

• Treating weight or an approved Wegovy cardiovascular use? → Ask about Wegovy tablets.
• Treating type 2 diabetes? → Ask about Ozempic tablets.
• Currently taking Rybelsus? → Do not swap milligram for milligram. Your prescriber needs to direct the transition.

Is Rybelsus discontinued?

Novo says Rybelsus has been replaced by Ozempic tablets in the United States. A May 21, 2026 notice to Illinois Medicaid providers said Novo would stop wholesaler shipments in May and expected remaining supply to become limited beginning in July. On June 4, 2026, FDA's drug database marked all three Rybelsus strengths as to be discontinued.

This transition is not described as a recall or a safety withdrawal. The new Ozempic tablet has a different formulation with higher bioavailability, which is why the milligram numbers changed.

Your dose number changes, and the smaller number is not automatically a smaller treatment step

The current Ozempic label says not to switch a patient who is still in the first 30 days on Rybelsus 3 mg.

A prescriber must direct the change. Do not assume the pharmacy will replace one bottle with another or that the numbers are interchangeable.

What the cash-price change can mean

That is a list-price comparison, not a promise that every Rybelsus patient currently pays $997.58. Insurance, pharmacy discounts, remaining supply, and eligibility can change the amount at the counter.

More detail: Rybelsus cost without insurance

Can insurance, an HSA, or Medicare make it cheaper?

Yes, but the three paths work differently. Eligible commercially insured patients whose plans cover Wegovy may pay as little as $25 with a maximum manufacturer savings of $100 per month. A narrower group of Medicare Part D enrollees can get selected GLP-1 drugs for $50 through the Medicare GLP-1 Bridge after prior authorization. Eligible HSA or FSA holders can pay the cash price with pre-tax funds, which is a tax advantage—not a lower pharmacy checkout price.

If you have commercial insurance that covers Wegovy tablets

Novo's current savings terms say an eligible patient with commercial coverage for Wegovy tablets may pay as little as $25 per 30-day bottle, with a maximum manufacturer savings of $100 per month. The offer has eligibility rules and excludes people enrolled in federal or state health programs with prescription coverage.

Coverage is still plan-specific. Ask your insurer or pharmacy about the tablet, not just Wegovy generally. Ro's public checker names selected injection pens, so we are not treating it as proof of Wegovy pill coverage.

If you have Medicare Part D — read this before paying cash

The Medicare GLP-1 Bridge runs from July 1, 2026 through December 31, 2027. It can provide covered GLP-1 drugs, including Wegovy tablets, for $50 per 30-day fill after prior authorization.

But Part D enrollment alone is not enough. CMS's prescriber criteria include all of these starting gates:

• Enrollment in an eligible Medicare prescription drug plan.
• The plan does not already cover a GLP-1 for the same use through its normal Part D benefit.
• The patient is an adult using the drug for weight management and does not have type 2 diabetes, moderate-to-severe obstructive sleep apnea, or MASH under the Bridge rules.
• The patient meets one of CMS's BMI-and-risk paths:
  • BMI 35 or higher, or
  • BMI 30 or higher plus heart failure with preserved ejection fraction, uncontrolled hypertension despite two medicines, or stage 3a-or-higher chronic kidney disease, or
  • BMI 27 or higher plus prediabetes, a prior heart attack, a prior stroke, or symptomatic peripheral artery disease.

The prescriber submits one prior-authorization request to the Bridge's central processor. Approval is not automatic.

If you qualify, $50 beats $149 and $299. Start with our Medicare GLP-1 Bridge guide or the official CMS Bridge page.

One more detail matters: the Bridge runs outside the normal Part D claims flow. The $50 does not count toward your Part D deductible, true out-of-pocket spending, or Low-Income Subsidy cost-sharing calculations.

Government-insured patients may still use Novo's separate self-pay offer only by paying outside insurance and agreeing not to submit the cost for reimbursement or deductible credit. That is different from the commercial copay savings card, which excludes government beneficiaries.

We make nothing sending you to the Medicare route. It is just the right answer when you qualify.

If you have an HSA or FSA

This is useful only if you actually have an eligible account with available funds.

Prescription medicine is generally an eligible medical expense, and NovoCare Pharmacy says it accepts HSA and FSA cards at checkout. That does not change the $149 price on the receipt. It lets eligible account holders use pre-tax dollars.

The tax-equivalent math at a 24% marginal tax rate looks like this:

That is an estimated $789.12 tax difference over the first-year $3,288 medicine schedule. Your real tax effect depends on your tax situation, account eligibility, contribution limits, and plan rules.

Two honest caveats. First, ask your plan administrator whether a telehealth membership or platform fee is eligible; medicine and program fees may be treated differently. Second, a self-pay prescription processed outside insurance does not count toward your insurance deductible or out-of-pocket maximum.

More detail: GLP-1 providers that accept HSA or FSA

Does the pill work as well as the shot?

The pill and shot produced similar average weight-loss numbers in separate major trials, but they were not tested head to head. In OASIS 4, the 25 mg Wegovy tablet produced a 13.6% average weight change at week 64 under the estimate that counted everyone as assigned, compared with 2.2% for placebo. A separate Wegovy injection trial reported 14.9% at week 68, compared with 2.4% for placebo. You cannot use those separate studies to declare a winner.

The tablet study was OASIS 4. It enrolled 307 adults without diabetes and assigned 205 to oral semaglutide 25 mg and 102 to placebo. Everyone also received lifestyle support. The treatment period lasted 64 weeks, followed by 7 weeks off treatment.

Why you may see both 13.6% and 16.6%

The 16.6% number is not simply “everyone who finished.” It is a model-based estimate under an idealized trial condition. The 13.6% number is the cleaner real-world-style headline because it keeps people in the result even when treatment changed or stopped.

The real trade-off is the routine

The injection is once a week. The tablet is once every morning with strict empty-stomach timing.

That is 52 planned injections a year versus 365 planned mornings. For some people, removing the needle is the only thing that makes treatment possible. For others, the daily timing is harder than one weekly injection.

Be honest with yourself about which routine you can follow. The more convenient format is the one you can use correctly after the excitement of month one wears off.

One more number worth knowing: gastrointestinal side effects were reported in 74.0% of the oral-semaglutide group and 42.2% of the placebo group in OASIS 4. Most were mild to moderate, and many occurred while the dose was increasing.

The Wegovy trial does not establish the result of a compounded lozenge, drop, gum, sublingual product, or alternate tablet. Those are different finished products.

Deeper comparison: Wegovy pill vs. injection

How do you take the semaglutide pill?

Take one Wegovy tablet in the morning on an empty stomach with no more than 4 ounces of plain water. Swallow it whole. Then wait at least 30 minutes before eating, drinking anything else, or taking another oral medicine. Do not split, crush, chew, or dissolve it.

Your morning, step by step:

1. Wake up with an empty stomach.
2. Take one tablet with up to 4 ounces of plain water—about half a small glass.
3. Swallow it whole. Do not split, crush, chew, or dissolve it.
4. Wait at least 30 minutes.
5. Then eat, drink, or take your other oral medicines.

Coffee does not count as plain water. Juice does not count. More water is not better here.

The tablet contains an absorption helper called SNAC. Semaglutide absorption mainly occurs in the stomach, and the label's data show that the amount of water and the wait time change how much medicine is absorbed. That is why the routine is not optional fine print.

What if you miss a dose?

Skip it. Take your next regular tablet the following day. Do not take two tablets to make up for the one you missed.

The morning-medicine collision to plan for

If you take levothyroxine, tell the prescriber before starting the Wegovy tablet. In a drug-interaction study, total thyroxine exposure increased by 33% when levothyroxine was taken with oral semaglutide. The label advises clinical or laboratory monitoring for oral medicines that need close monitoring.

Do not invent your own spacing plan from a blog. Ask the clinician who manages your thyroid medicine how to time the two drugs and whether testing needs to change.

Consider the weekly injection instead if you cannot reliably keep the empty-stomach window, you take another time-sensitive morning medicine, you travel across time zones often, or you already know a daily dose will be harder to remember than a weekly one.

Who should not take the semaglutide pill?

Do not use Wegovy if you or a family member has had medullary thyroid carcinoma, if you have Multiple Endocrine Neoplasia syndrome type 2, or if you have had a serious allergic reaction to semaglutide or a Wegovy ingredient. For weight or cardiovascular use, stop Wegovy when pregnancy is recognized and stop it at least two months before a planned pregnancy. Breastfeeding is not recommended while taking the tablets.

Those are not the only questions a prescriber needs to ask.

Tell the prescriber before you start if any of these apply

• A personal or family history of medullary thyroid carcinoma or MEN 2. These are contraindications, not small cautions.
• A prior serious allergic reaction to semaglutide or a Wegovy ingredient.
• Pancreatitis or severe, lasting abdominal pain in the past.
• Gallstones or other gallbladder problems.
• Kidney problems, especially if vomiting or diarrhea could dehydrate you.
• Severe stomach-emptying problems, including severe gastroparesis. Wegovy is not recommended for severe gastroparesis.
• Type 2 diabetes, insulin use, or a sulfonylurea. Blood sugar monitoring and dose changes may be needed.
• Diabetic eye disease. Rapid glucose improvement can temporarily worsen diabetic retinopathy in some patients.
• A racing or pounding heartbeat at rest. The label calls for heart-rate monitoring and says to report lasting palpitations.
• Pregnancy, a plan to become pregnant, or breastfeeding.
• An upcoming surgery or procedure with general anesthesia or deep sedation. Wegovy delays stomach emptying, so the procedure team needs to know.
• Every prescription, over-the-counter medicine, and supplement you take, especially oral medicines that need close monitoring.

Also, do not combine Wegovy with another semaglutide product or another GLP-1 receptor agonist.

Get urgent medical help when the symptom is urgent

Call emergency services for signs of a serious allergic reaction, such as swelling of the face, lips, tongue, or throat; trouble breathing or swallowing; severe rash or itching; fainting; or a very fast heartbeat.

Call the prescriber promptly for severe abdominal pain that will not go away, especially when it moves toward the back or comes with vomiting; signs of a gallbladder problem; ongoing vomiting or diarrhea; a major vision change; a racing or pounding heartbeat that lasts; or symptoms of very low blood sugar if you also use diabetes medicine.

This is not the complete prescribing information. Read the current Wegovy Prescribing Information and the Medication Guide. If a contraindication or serious warning applies to you, none of the prices on this page matter yet.

What happens if you cancel?

The medicine, the care plan, the prescription, and any prepaid medication commitment are separate things. Canceling one charge does not promise future refills, ongoing dose management, or a refund of another charge. Know all four answers before you prepay.

This is the fear that keeps people from clicking, so let us just handle it.

Before you cancel anything, run this list:

1. When is my next care-plan billing date?
2. Has the next medicine fill already been ordered or charged?
3. Who controls my prescription after I cancel?
4. Who handles the next dose change or side-effect question?
5. Have I saved my treatment records and current medication list?
6. Is any prepaid care or medicine amount refundable, and how is the refund recalculated?

And one that is not about money: do not stop or change a GLP-1 just because a subscription ended. Contact the prescribing clinician and make a clinical plan.

How we checked these prices

Every fixed price and policy in this article was checked against an official manufacturer, government, pharmacy, provider, study, label, court, or company filing available on August 22, 2026. We did not copy another comparison table. When a headline and the actual billing terms differed, we used the terms. When the source could not support a claim, we removed or narrowed it.

Provider-stated headline vs. what we verified

What we verified at the source

• Novo Nordisk's self-pay prices for Wegovy tablets, the 4 mg fill deadline, and the commercial copay-offer terms.
• The FDA-approved tablet dose schedule, administration instructions, contraindications, warnings, pregnancy language, breastfeeding language, and levothyroxine interaction.
• The Ozempic tablet strength prices and current Rybelsus-to-Ozempic transition instructions.
• NovoCare Pharmacy's HSA/FSA acceptance and prescriber routing details.
• Ro's $39 first month, $149 monthly renewal, $888 annual care price, and separate medicine charge.
• GoodRx Care Direct's $39 monthly price, automatic renewal, cancellation timing, and Alabama/Louisiana exclusion.
• Walgreens' $49 initial visit and $49 follow-up pricing.
• Sesame's $99 every-28-days billing, annual discount, first-visit refund window, and separate medicine cost.
• The Medicare GLP-1 Bridge dates, $50 price, prior authorization, eligibility gates, and treatment outside the normal Part D claim flow.
• FDA's April 30, 2026 503B proposal, FDA's general compounding rules, the Strut warning letter, and FDA's reported compounded-semaglutide adverse-event count.
• The Hims launch, withdrawal, lawsuit, dismissal without prejudice, and later shift toward FDA-approved products.
• OASIS 4's 13.6% treatment-policy result, 16.6% idealized result, sample size, and gastrointestinal-event rates.

What we could not lock down—and are not promising

• A specific retail pharmacy's inventory, same-day availability, or exact counter price before it processes the offer.
• Your eligibility for a prescription, a savings offer, the Medicare Bridge, or a provider's program.
• Whether every online program has a clinician licensed and accepting patients in your state on the day you apply.
• Optional labs, taxes, add-ons, failed-payment fees, or services not included in the public base price.
• The exact number of Walgreens follow-ups you will need.
• A clinical result for the specific compounded lozenges, drops, sublingual products, or alternate tablets in our price table.
• A claim that an adverse-event report proves the compounded product caused the event; FDA says many reports lack enough information to determine causality.

How we calculated the totals

• Medicine schedule: $149 for the 1.5 mg bottle + $149 for the qualifying 4 mg bottle + ten $299 maintenance bottles.
• Standard-price adjustment: add $50 when the 4 mg bottle costs $199.
• 90-day total: medicine for the first three 30-day treatment periods + every required care charge that falls inside the first 90 calendar days.
• First-year total: medicine used in the first twelve 30-day treatment periods + required care fees under the provider's actual billing clock.
• Sesame monthly: thirteen 28-day care charges land within the first 364 days.
• Annual plans: we count the full upfront care charge when it is due, not a softened monthly equivalent.
• Walgreens: we leave follow-ups as $49 × paid visits because a fixed number would be invented.

We excluded optional add-ons, discounts we could not verify at the source, taxes not shown publicly, and coupon stacking that the offer does not clearly allow.

Primary sources

• NovoCare Wegovy savings and self-pay terms
• Wegovy Prescribing Information
• NovoCare Pharmacy Wegovy page
• NovoCare Ozempic pill price guide
• WeightWatchers Wegovy pill and medication-commitment terms
• OASIS 4 study abstract at PubMed
• STEP 1 Wegovy injection trial at PubMed
• Ro weight-loss pricing
• GoodRx Care GLP-1 program
• Walgreens Wegovy weight-management program
• Sesame online weight-loss program
• CMS Medicare GLP-1 Bridge
• FDA compounding questions and answers
• FDA's April 30, 2026 503B proposal
• Strut Health oral semaglutide product page
• FDA warning letter to Strut Health
• Shed weight-loss product page
• DirectMeds semaglutide product page
• FDA concerns with unapproved GLP-1 drugs
• Hims February 5 compounded-pill announcement
• FDA's February 6 GLP-1 marketing statement
• Novo Nordisk's March 9 Hims agreement announcement
• Illinois HFS notice on the Rybelsus-to-Ozempic tablet transition
• FDA Orange Book resources
• FDA Foundayo approval announcement

Who we are and what we earn

Weight Loss Provider Guide is an independent comparison resource for GLP-1 telehealth providers.

We may earn a commission if you start a program through links to Ro, Sesame, Hims, or Hers. We have no financial relationship with NovoCare Pharmacy, GoodRx, Walgreens, CMS, or your own clinician. Those routes are here because, for many readers, they are cheaper or more appropriate.

Our ranking puts the cheapest honest path first whether it pays us or not. That is why “your own clinician” is the first row of the main cost table.

Page change log:

Frequently asked questions

What is the cheapest semaglutide pill without insurance?

The cheapest FDA-approved semaglutide pill without insurance is the 1.5 mg Wegovy tablet at $149 for a 30-day bottle under Novo's current self-pay terms. The 4 mg bottle is also $149 only when filled by August 31, 2026; its standard price is $199. You still need a prescription, and any care fee is separate.

Is the Wegovy pill really $149?

Yes. The 1.5 mg bottle is $149 under the current self-pay offer. The price does not include a clinician visit, membership, lab work, or the later 9 mg and 25 mg bottles. Eligibility, participating-pharmacy processing, stock, and current terms apply.

How much does the semaglutide pill cost after the first month?

The label schedule uses 1.5 mg for days 1–30, 4 mg for days 31–60, 9 mg for days 61–90, and 25 mg from day 91 onward. Current published prices are $149, then either $149 or $199 for 4 mg depending on the fill deadline, then $299 for 9 mg and 25 mg.

How much does a full year of the Wegovy pill cost without insurance?

The medicine used during the first twelve treatment months is $3,288 when the 4 mg bottle qualifies for the temporary $149 price, or $3,338 at the standard $199 4 mg price. Add the clinician or care-plan cost. A 12-fill maintenance commitment can lower the medicine used in year one to $2,788, but the verified version asks for $2,988 up front for all 12 maintenance fills.

Can I get a semaglutide pill without a prescription?

No. FDA-approved semaglutide is prescription-only in the United States. A legitimate online program still requires an evaluation and a prescription from a licensed clinician.

Is there an FDA-approved generic semaglutide pill?

No. There is no FDA-approved generic semaglutide. Compounded semaglutide is not an FDA-approved generic equivalent, and a seller should not market it as one.

Are compounded semaglutide pills FDA-approved?

No. The finished compounded lozenges, drops, sublingual products, gums, and alternate tablets do not go through FDA approval. A lawful patient-specific compounded prescription may still be used when the legal and clinical requirements are met, but it is a different evidence and regulatory lane from Wegovy.

Is Rybelsus the same as the Wegovy pill?

No. Both contain semaglutide, but they have different labels, formulations, doses, and approved uses. Rybelsus is being replaced by Ozempic tablets in the United States. Do not switch milligram for milligram without a new prescriber-directed plan.

Is Foundayo a semaglutide pill?

No. Foundayo contains orforglipron, a different GLP-1 medicine made by Eli Lilly. FDA approved it in April 2026 for chronic weight management in certain adults. It also does not require the same empty-stomach routine as the semaglutide tablet. See our oral GLP-1 comparison for that separate decision.

Do I need a membership to get the $149 medicine price?

No. Novo's medicine-only self-pay path does not require a Ro, GoodRx Care, Sesame, or Walgreens membership. You still need a valid prescription, and participating-pharmacy processing and offer terms apply.

Does Ro's price include the medicine?

No. Ro's $39 first month and $149 monthly renewal are care fees. Medicine is separate. With the $149 starter bottle, month one is about $188. With $149 monthly care and the $299 maintenance bottle, the ongoing total is $448 per month.

Is Walgreens cheaper than Ro or GoodRx?

Not in month one under the prices we verified. Walgreens starts at $198: a $49 visit plus the $149 bottle. GoodRx Care Direct and Ro each start at $188. Walgreens can still cost less over time when you need only a few $49 follow-ups because it does not have a monthly subscription.

Can I stay on a lower dose to keep the price down?

Not as a money choice. The label sets 25 mg once daily as the tablet maintenance dose. A prescriber may delay an increase when a dose is not tolerated, and may consider a switch to the injection when 25 mg is not tolerated. Do not change the dose on your own to chase a price.

Can I use HSA or FSA money?

Eligible account holders can generally use HSA or FSA funds for prescription medicine, and NovoCare Pharmacy says it accepts HSA and FSA cards at checkout. That is a pre-tax payment advantage, not a lower pharmacy price. Ask your plan administrator separately about telehealth membership fees.

Can Medicare patients get Wegovy tablets for $50?

Some can through the Medicare GLP-1 Bridge from July 1, 2026 through December 31, 2027, but Part D enrollment alone is not enough. The patient must meet the Bridge's plan, diagnosis, BMI, risk, and prior-authorization rules. The $50 Bridge payment does not count toward the normal Part D deductible or true out-of-pocket total.

Can a government-insured patient use Novo's $149 self-pay offer?

The commercial copay savings card excludes government-program beneficiaries. Novo's separate self-pay terms may allow a government-insured patient to pay outside insurance, but the patient must not seek reimbursement or count that payment toward an insurance deductible or out-of-pocket maximum. Confirm the current terms before filling.

Is the Wegovy pill available in every state?

The drug has federal approval, but local stock, offer processing, and telehealth clinician availability can vary. GoodRx Care Direct specifically says it is not available in Alabama or Louisiana. Check the medicine, prescriber, and pharmacy separately before paying a care fee.

What should I check before paying an online provider?

Ask these seven questions: Is this the FDA-approved Wegovy tablet or a compounded product? Who writes the prescription? Is medicine included or separate? What is charged today? When does the care plan renew? What does the 9 mg or 25 mg month cost? What happens to refills and prepaid money if I cancel?

Still not sure which GLP-1 route is right for you?

Take our free 60-second matching quiz.

Pill or injection. Insurance or cash. Existing clinician or no clinician. Your state, your budget, and the routine you can actually follow. You will get a next-step path—not a wall of provider logos.

→ Find My GLP-1 Path

Weight Loss Provider Guide is an independent comparison resource for GLP-1 telehealth providers. This article is for general information and is not medical advice. A licensed healthcare professional must decide whether a medication and dose are appropriate for you. Prices and terms were verified August 22, 2026 and can change.

Related: Cheapest Wegovy online · Wegovy pill vs. injection · Best GLP-1 pill provider · Compounded oral GLP-1 guide · Medicare GLP-1 Bridge · HSA/FSA GLP-1 providers · Advertising disclosure